Skip to content
Back to PLYX

Polaryx Therapeutics, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
2
Purchases
2
Sales
0
Purchase value
$367.99K
Sale value
$0.00

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Partners Healthcare Ltd MstoneDirector · 10% owner
Alex Keun Mo YangDirector · Chief Executive Officer · 10% owner
4
Filed May 28, 2026Period of report May 27, 20260001213900-26-062322
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseMay 27, 2026
Common StockF1F288,453$4.07$360.00K24,233,249IndirectBy Mstone Partners Healthcare Limited
Filing footnotes · 2
  1. F1As disclosed in the Issuer's Form 8-K filed with the Securities and Exchange Commission on May 28, 2026, MStone Partners Healthcare Limited ("Mstone") purchased 88,453 shares of common stock in a private placement transaction, for gross proceeds to the Issuer of $360,000.
  2. F2Alex Keun Mo Yang is the founder and Chief Executive Officer of Mstone. Mr. Yang disclaims beneficial ownership over any of the reported securities, except to the extent of his pecuniary interest therein.
Open on SEC EDGAR
G. Michael LandisDirector · Chief Financial Officer
4
Filed Feb 20, 2026Period of report Feb 18, 20260001213900-26-018845
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseFeb 18, 2026
Common Stock2,867$2.7871$7.99K228,225Direct
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.